Quantitation of cord blood low density lipoprotein cholesterol (C-LDL), kindred studies, and longitudinal assessment allows the neonatal diagnosis of familial hypobetalipoproteinemia. To assess the relationship between neonatal hypobetalipoproteinemia and C-LDL in later infancy, kindred studies with follow-up were carried out in 11 families with a hypobetalipoproteinemic neonatal propositus, and in two families with normal neonates and hypobetalipoproteinemic adult propositi. Neonatal and familial hypobetalipoproteinemia was diagnosed in one kindred by quantitation of cord blood C-LDL, four-generation vertical transmission, and by demonstration of persistent hypobetalipoproteinemia in later infancy. In a second kindred, the neonate and her father, grandfather, and half-siblings had hypobetalipoproteinemia, but her C-LDL was normal (96 mg/dl) at age 6 months. Whether this unexpectedly normal C-LDL will persist, with a resultant "false positive" diagnosis at birth, can only be determined by longitudinal study. In a third kindred the hypobetalipoproteinemic neonate retained low C-LDL at age 2 years, the mother had borderline-low C-LDL levels, but there were no living siblings or maternal first degree relatives and familial hypobetalipoproteinemia could not be confirmed. The remaining eight hypobetalipoproteinemic neonates had normal C-LDL on follow-up examination; kindred studies failed to reveal familial hypobetalipoproteinernia. Two neonates with normal cord blood C-LDL, born to hypobetalipoproteinemic parents, retained normal C-LDL levels in infancy.
Familial hypobetalipoproteinernia is characterized by sharply reduced levels of plasma total and C-LDL (1) (2) (3) 11) . It rarely is accompanied by clinical symptoms or physical findings and is underdiagnosed and little recognized (2) . Although there were only five well described kindreds as recently as 1972 (3), eight additional kindreds have been identified in Cincinnati population lipid and lipoprotein surveys (5). Kindreds with familial hypobetalipoproteinernia have prolonged life expectancy and reduced cardiovascular morbidity and mortality, putatively related to low levels of C-LDL, the primary atherogenic lipoprotein (5).
Most studies have focused on the upper 5th percentile of the C-LDL distribution and on familial hypercholesterolemia (9, 15, 16) , because of the acceleration of premature atherosclerosis in affected adults (14) . The recent evidence of the protective "anti-coronary risk" nature of low C-LDL (in familial hypobetalipoproteinemia) and elevated C-HDL (in familial hyperalphalipoproteinemia) (5), has augmented interest in neonates having exceptionally low C-LDL and high C-HDL.
Quantitation of cord blood C-LDL, kindred studies, and longitudinal assessment allows the neonatal diagnosis of familial hypobetalipoproteinernia (8) . Presumably, in a manner similar to neonatal hyperbetalipoproteinemia ( I s ) , a majority of hypobetalipoproteinemic neonates do not have "monogenic" hypobetalipoproteinemia. This study focused on the relationship between neonatal hypobetalipoproteinernia and C-LDL in later infancy, with emphasis on hypobetalipoproteinernia of a heritable or other unknown origin, in 11 families with a hypobetalipoproteinemic neonatal propositus, and in 2 families with normal neonates and hypobetalipoproteinemic adult propositi.
MATERIALS AND METHODS

LIPID AND LIPOPROTEIN QUANTITATION
Cord blood total cholesterol and C-LDL were quantitated in propositus neonates during a study of plasma lipids in 3000 unselected live births (16) . Cord blood total, C-HDL, C-LDL, very low density lipoprotein cholesterol (C-VLDL), and triglyceride were determined as previously reported (15, 16) .
The low 2.5th percentile limits for cord blood total cholesterol and C-LDL were taken from 60 neonates whose parents had normal cholesterol and triglycerides (15) . The distribution of C-LDL in 117 unselected neonates (6) was also examined to provide comparison with that previously described in the 60 neonates (15) .
Lipid and lipoprotein determinations in other kindred members were done following the Lipid Research Clinics Program methods (10) . For assessment of adult and other pediatric kindred members, upper normal limits of Fredrickson and Levy for cholesterol, triglyceride, and C-LDL were used (4). The triglyceride upper limits of Fredrickson and Levy (4) are probably too low, based on the preliminary experience of the Lipid Research Clinics Program, and all of the Fredrickson lipid and lipoprotein limits will probably be somewhat altered upon receipt of the final prevalence studies of the Lipid Research Clinics.
The 2.5th percentile for C-LDL in the 60 neonates (15) was 10 mg/dl, and in our separate study of 117 neonates, 12 mg/dl (6). In Stein's study (13) of 494 unselected births, the 2.5th percentile for C-LDL was 14 mg/dl, using comparable laboratory methods. The lower C-LDL limits in the study of Fredrickson et al. (4) for ages 0-19, 20-29, 30-39, 40-49, and 50-59 years were, respectively, 50, 60, 70, 80, and 90 mg/dl (4). Unusual causes for acquired hypobetalipoproteinernia (1-3) such as hyperthyroidism, hepatic necrosis, severe anemia, acute trauma, fat malabsorption, and myeloma anti-beta-antibodies were excluded in kindred members.
STUDY PROTOCOL
After recognizing that neonates with cord blood C-LDL 5 the 2 5 t h percentile might have familial hypobetalipoproteinernia (7), we focused on this area of the C-LDL distribution in 3000 infants, who, with their parents, had previously been sampled (16) . Since the initial cord blood lipoprotein survey was concerned with the opposite end of the distribution (the upper 5th percentile for C-LDL for the diagnosis of neonatal familial hyperbetalipoproteinemia (16), we-had not prospectively followed any of the 11 kindreds finally selected from the low percentiles.
In 3000 neonates, there are by definition, approximately 75 with C-LDL in the bottom 2.5% of the distribution. All kindreds with infants whose cord blood C-LDL levels were 5 1 0 mg/dl (the 2.5th percentile) (7) were sent letters explaining our interest in "low" plasma cholesterol levels at birth and inviting participation with resampling of parents, infants, and where possible, the neonates' grandparents and siblings. Twenty percent of the kindreds (15 families) with a hypobetalipoproteinemic neonate had moved from Cincinnati, and were unavailable for follow-up. In 32 kindreds where antecedent studies (16) had revealed low plasma cholesterol levels among parents of hypobetalipoproteinemic infants, maior efforts were expended, thus biasing the data to familial aggregations of hypdbetalipoproteinemia. No systematic attempt was made to obtain samples from all kindreds identified by neonates with C-LDL 5 1 0 mgldl. The number of kindreds eventually found to have familial and neonatal hypobetalipoproteinemia possibly underestimates the prevalence of the trait, as diagnosed at birth.
In two kindreds with adult hypobetalipoproteinemic propositi (5), cord blood samples were available in newborns from familial hypobetalipoproteinemia X normal matings.
All follow-up evaluations were done at the out-patient General Clinical Research Center, with blood in adults and children over age 2 drawn after a 12-hour fast. Infants were allowed fruit juice and dry toast before sampling.
Confirmation of the diagnosis of familial hypobetalipoproteinemia in the kindreds with propositus neonates required the following (7): (1) presence of primary hypobetalipoproteinemia in the neonate, a parent, and a grandparent (three-generation vertical transmission of hypobetalipoproteinemia); (2) persistent hypobetalipoproteinemia on follow-up sampling of the infant.
RESULTS
NEONATAL HYPOBETALIPOPROTEINEMIA
Of the approximately 75 potential hypobetalipoproteinemic kindred, 11 were longitudinally studied. The selection process for inclusion into the study required availability of the infant for resanpling after birth, was biased toward families with parental hypocholesterolemia, and was not prospective, thus being nonsystematic. Of the 11 kindreds identified by a hypobetalipoproteinemic neonatal propositus, three-generation vertically transmitted familial hypobetalipoproteinemia was documented in 2. In kindred 1, the subject of a preliminary report (8) , the neonate, her father (C-LDL 39), paternal grandmother (C-LDL 50), and paternal greatgrandmother (C-LDL 61) had familial hypobetalipoproteinemia (Table 1) . Follow-up at age 1.5 years revealed persistent hypobetalipoproteinernia, C-LDL 19 mgldl (Table 1) . In kindred 2, an adult male with documented familial hypobetalipoproteinernia (2) married a normolipidemic woman, aft& his initial marriage to a distant relative (also with hypobetalipoproteinemia) had produced one child heterozygous for the trait (C-LDL 37), and two children homozygous for the trait with a-betalipoproteinemia (2). The hypobetalipoproteinemic neonate of his second marriage (Table I ) , a half-sib of the older homo-and heterozygotes (2), was one of the 3000 livebirths studied (16) . A paternal grandfather had hypobetalipoproteinemia, C-LDL 40 mg/dl (2) . Unexpectedly, at 6 month followup, the infant had normal C-LDL, 96 mgldl, Table 1 .
In kindred 7 the infant's mother had low normal C-LDL, 65 mgldl, just above the age-specific cutpoint of 60 mgldl (4). There were no living siblings or maternal first degree relatives, and familial hypobetalipoproteinernia was suspected, but could not be confirmed. At age 2 years, the propositus infant retained low levels of C-LDL, 32 mg/dl (Table 1) .
Familial hypobetalipoproteinemia was not demonstrated in any of the remaining eight kindreds with a hypobetalipoproteinemic neonatal propositus. In four kindreds (kindreds 8, 9, 10, and 1 I ) , parental C-LDL levels were normal and C-LDL levels in the infants at follow-up were normal (83, 100, 90, and 77 mg/dl, Table 1 ). In three kindreds (kindreds 4 , 5 , and 6), one parent had primary hypobetalipoproteinemia, with C-LDLs of 63, 43, and 55 mg/dl (Table 1) . No other family members in these three kindreds had primary hypobetalipoproteinernia, and C-LDL at follow-up in the three infants was normal (89, 93, 96 mg/dl, Table 1 ).
In kindred 3 , family studies revealed four-generation vertical transmission of familial hyperalphalipoproteinemia (6). The infant's C-LDL on follow-up was normal, 79 mgldl, whereas her C-HDL was distinctively elevated at 101 mgldl (Table 1) . PARENTAL 
HYPOBETALIPOPROTEINEMIA
Two kindreds were studied with well defined familial hypcbetalipoproteinemia (kindreds 12 and 13, Table 1 ) (5). Two neonates born to a mating of familial hypobeta-X-normal had normal cord blood cholesterol and C-LDL, with normal cholesterol and C-LDL in later infancy (Table 1) .
CLINICAL STUDIES
When repeat blood samples were obtained from the 11 hypobetalipoproteinemic propositus infants, physical and gross neurologic examinations were normal, as were growth and developmental milestones.
DISCUSSION
Neonatal and familial hypobetalipoproteinemia (8) was diagnosed in one kindred by quantitation of cord blood C-LDL, four-generation vertical transmission, and by demonstration of persistent hypobetalipoproteinemia in later infancy. In a second kindred, the neonate and her father, grandfather, and halfsiblings had hypobetalipoproteinernia, but the infant's C-LDL was normal, 96 mg/dl, at age 6 months. Whether this unexpectedly normal C-LDL will persist, with a resultant "false positive" diagnosis at birth, can only be determined by longitudinal studies. In a third kindred the hypobetalipoproteinernic neonate retained low C-LDL at age 2 years. Her mother had borderlinelow C-LDL levels, but there were no living siblings or maternal first degree relatives, and familial hypobetalipoproteinemia could not be confirmed. The remaining eight hypobetalipoproteinemic neonates had normal C-LDL on follow-up examination; kindred studies failed to reveal familial hypobetalipoproteinemia. Similar to the report by Naito and Lewis (12) , two neonates with normal cord blood C-LDL born to hypobetalipoproteinemic parents retained normal C-LDL levels in infancy.
The 2.5th percentile for C-LDL, 10 mg/dl (15), used to identify neonatal hypobetalipoproteinernia, was comparable to 12 mg/dl for 117 neonates (6) and 14 mg/dl for 494 neonates (13) .
Although this study did not systematically include all kindreds from the 3,000 kindred cohort (16) with neonatal C-LDL 5 1 0 mg/dl, an estimated prevalence of familial hypobetalipoprotenemia would appear to be 1 in 3000, with the caveat that with is then considerably more common than previously suspected 5. Glueck, C. J., Gartside, P., Fallat, R . W., Sielski, J., and Steiner, P. M.: . . beta~ipo~roteinemia in a study of 494 neonates.
Cord blood and kindred lipoprotein studies may identify families having heritable "anti-coronary risk" factors (7, 8) .
Future studies of cord blood lipids and lipoproteins will allow a prospective systematic study of all hypobetalipoproteinemic neonates and their kindreds with an aim at more exact delineation of prevalence and "natural history" during infancy and childhood.
